Sirius Therapeutics Co., Ltd.

This study tests an investigational drug called SRSD107 in 104 adults with long-term coronary or peripheral artery disease. Participants receive multiple injections of the drug or a placebo, while continuing aspirin. The goal is to see if the drug safely lowers a clotting protein…

This study tests a new medication called SRSD107 to see if it can prevent dangerous blood clots (venous thromboembolism) better than the standard drug enoxaparin in people having knee replacement surgery. About 450 adults aged 60 to 80 will receive either SRSD107 or enoxaparin fo…

This study tests an experimental drug called SRSD216, given as an injection under the skin, in people with high levels of lipoprotein(a) – a genetic risk factor for heart disease. The trial has two parts: first to check safety and find the right dose, then to confirm the dose in …